Thus, M2 macrophage-derived exosomal AGAP2-AS1 enhances radiotherapy immunity in lung cancer by reducing miR-296 and elevating NOTCH2 (Zhang F. et al., 2021). This evidence concerns the gene AGAP2 and lung cancer.